Blockade of gamma-secretase activity to promote myelination by oligodendrocytes
View Patent ↗Methods are provided for enhancing myelination. Myelination is enhanced by administration of agents that are inhibitors of γ-secretase. Methods of screening for pharmaceutically active compounds that enhance myelination, and for genes involved in myelination are also provided.
1. A method of enhancing CNS myelination in a patient having a CNS disorder characterized by a myelin deficiency, the method comprising:
contacting an oligodendrocyte or progenitor thereof in the proximity of an axon in a patient having a CNS disorder characterized by a myelin deficiency with an effective dose of an inhibitor of γ-secretase;
wherein the myelination of said axon is enhanced in said patient.
2. The method according to claim 1 , wherein said inhibitor of γ-secretase is a genetic agent.
3. The method according to claim 1 , wherein said inhibitor of γ-secretase is a pharmacologic agent.
4. The method according to claim 1 , wherein said CNS disorder characterized by a myelin deficiency is a demyelinating disorder.
5. The method according to claim 4 , wherein said demyelinating disorder is multiple sclerosis.